Prevalence of hypertension in adults in the Šumadija District, Serbia – A cross-sectional study
Abstract
Background/Aim. World Health Organization (WHO) studies on the global level have shown that one of the major problems of the public health is hypertension. Blood pressure level greater than 140/90 mmHg is directly and predictively linked to other cardiovascular diseases. The aim of this research was to determine the prevalence of hypertension and the risk groups among the adult population in the Šumadija District, Serbia. Methods. This cross-sectional study included 1.669 elderly population of the Šumadija District, aged 25–74. The study was performed according to the protocol of the Countrywide Integrated Noncommunicable Disease Intervention (CINDI) international program. Results. In the Šumadija District more than a half of the population aged 25–74 suffers from hypertension (53%). In the Šumadija District 9% of population has undiagnosed hypertension. In the group of people familiar with their high blood pressure problems, good disease control is achieved in only 46% of them. Statistically, hypertension occurs more frequently in males aged 45–74, of lower education, and in rural population. This is the target group for implementation of the high risk strategy. Statistically, there is a higher prevalence of hypertension in people suffering from myocardial infarction (p = 0.04), angina pectoris (p = 0.00), other cardiac diseases (cardiac insufficiency) (p = 0.00) and cerebrovascular crises (p = 0.04). Conclusion. A continuous increase of patients with hypertension, coupled with the developed complications and increase in cardiovascular diseases as a cause of death, points to the lack of effective access to prevention and early detection of these diseases in the primary health care among the risk groups in Šumadija.
References
World Health Organization. Regional Office for Europe. European mortality database (MDB).Available from: http://data.euro.who.int/hfamdb/ [update July 2013].
Panev G. The age and sex structure of the population. In: Panev G, editor. The population and households in Serbia, Census 2002. Belgrade: National Statistical Institute, Institute of Social Studies − Center for Demographic Studies, Demographics of Serbia; 2006. p. 109−38. (Serbian)
Luepker RV, Arnett DK, Jakobs DR Jr, Duval SJ, Folsom AR, Armstrong C, et al. Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart Survey. Am J Med 2006; 119(1): 42−9.
Đokić D. Epidemiological data, risk factors, and sociomedical significance of chronic non-infections diseases. Kragujevac: Institute of Public Health; 2011. (Serbian)
The health condition of Serbian citizens − A 1997−2007 ana-lytical study. Belgrade: Institute of Public Health „Dr Milan Jovanović-Batut“; 2008. (Serbian)
Orte Martínez LM. High blood pressure at the crossroads: Looking for a Working Definition. Nefrologia 2010; 30(4): 394−402.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455): 217−23.
Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Se-lected major risk factors and global and regional burden of disease. Lancet 2002; 360(9343): 1347−60.
Đokić D. Healthcare quality and outcames in arterial hyperten-sion. Belgrade: Institute of social medicine, statistics, and medical research at the School of Medicine, University of Bel-grade; 1999. (Serbian)
Đokić D, Ilić M. The health condition of Šumadija citizens − A 1998−2008 analitical study. Kragujevac: Institute of Public Health; 2009. (Serbian)
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Commit-tee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6): 1206−52.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Ar-terial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hyperten-sion (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25(6): 1105−87.
Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36(3): 646−61.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903−13.
Tolonen H, Hermann W, Jakovljevic D, Kuulasma K, European Haelth Risk Monitoring (EHRM) Project. Review of surveys for risk factors of major chronic diseases and comparability of the results. Finnish National Public Health Institute 2002. Available from: http://www.ktl.fi/publications/ehrm/product1/title.htm [up-date October 2002].
Ma J, Stafford RS. Screening, treatment, and control of hyper-tension in US private physician offices, 2003-2004. Hyperten-sion 2008; 51(5): 1275−81.
Fields LE, Burt VL, Jeffery Cutler A, Hughes J, Roccella EJ, Sorlie P. The Burden of Adult Hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004; 44(4): 398−404.
Tu K, Chen Z, Lipscombe LL, Canadian Hypertension Education Pro-gram Outcomes Research Taskforce. Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ 2008; 178(11): 1429–35.
Piccini RX, Victora CG. Systemic arterial hypertension in a ur-ban area of southern Brazil: prevalence and risk factors. Rev Saude Publica 1994; 28(4): 261−7. (Portuguese)
Cipullo JP, Martin JF, Ciorlia LA, Godoy MR, Cação JC, Loureiro AA, et al. Hypertension prevalence and risk factors in a Brazil-ian urban population. Arq Bras Cardiol 2010; 94(4): 519−26. (Portuguese)
Barreto SM, Passos VM, Firmo JO, Guerra HL, Vidigal PG, Lima-Costa MF. Hypertension and clustering of cardiovascular risk factors in a community in Southeast Brazil-The Bambuí Health and Ageing Study. Arq Bras Cardiol 2001; 77(6): 576−81.
Banegas JR, Segura J, Sobrino J, Rodríguez-Artalejo F, de la Sierra A, de la Cruz JJ, et al. Effectiveness of blood pressure control out-side the medical setting. Hypertension 2007; 49(1): 62−8.
Plantinga LC, Miller ER 3rd, Stevens LA, Saran R, Messer K, Flow-ers N, et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension 2009; 54(1): 47−56.
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hy-pertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27(11): 2121−58.
Arguedas JA, Perez MI, Wright JM. Treatment blood pressure targets for hypertension. Cochrane Database Syst Rev 2009; (3): CD004349.
Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens 2009; 27(5): 923−34.
McMahon S, Neal B, Rodgers A. Hypertension-time to move on. Lancet 2005; 365(9464): 1108−9.
Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115(5): e69−171.
Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trials. Hypertens Res 2005;28(5): 385−407.
